Literature DB >> 15737564

Hypermethylation of CpG islands in the promoter region of the p15INK4B gene in childhood acute leukaemia.

Erasmia Tsellou1, Constantinos Troungos, Maria Moschovi, Fani Athanasiadou-Piperopoulou, Sophia Polychronopoulou, Helen Kosmidis, Maria Kalmanti, Angelos Hatzakis, Nick Dessypris, Anastasios Kalofoutis, Eleni Petridou.   

Abstract

It has been reported that the cyclin-dependent kinase inhibitor (CDKI) gene p15INK4B is frequently inactivated by genetic alterations and may be responsible for various malignant tumours. Another way of inactivation of this CDKI is by hypermethylation of 5'CpG islands in the promoter region of the p15INK4B gene and this inactivation seems to be a frequent event in various haematological malignancies. In the present study, we investigated the methylation status of the p151NK4B gene to clarify its role in the pathogenesis of childhood acute myeloid (AML) and acute lymphoblastic leukaemia (ALL). The study included 23 cases of B-cell origin ALL, 13 cases of T-cell origin ALL, 32 cases of AML, and 10 apparently healthy controls. Hypermethylation was studied by methylation-specific polymerase chain reaction. Hypermethylation of the p15INK4B gene was more frequent in cases with T-cell origin ALL (46.2%), but similar among children with B-cell origin ALL (13.0%) and AML (18.8%). Hypermethylation of p15INK4B may be involved in the pathogenesis of T-cell origin ALL, but not in that of AML or B-cell origin ALL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15737564     DOI: 10.1016/j.ejca.2004.12.010

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

1.  Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia.

Authors:  Seisho Takeuchi; Masahide Matsushita; Martin Zimmermann; Takayuki Ikezoe; Naoki Komatsu; Taku Seriu; Martin Schrappe; Claus R Bartram; H Phillip Koeffler
Journal:  Leuk Res       Date:  2011-05-17       Impact factor: 3.156

Review 2.  Latest Contributions of Genomics to T-Cell Acute Lymphoblastic Leukemia (T-ALL).

Authors:  Eulàlia Genescà; Celia González-Gil
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

Review 3.  p15Ink4b Functions in determining hematopoietic cell fates: implications for its role as a tumor suppressor.

Authors:  Linda Wolff; Juraj Bies
Journal:  Blood Cells Mol Dis       Date:  2013-02-09       Impact factor: 3.039

4.  Hypermethylation of p15 gene associated with an inferior poor long-term outcome in childhood acute lymphoblastic leukemia.

Authors:  Huirong Mai; Xiaolan Liu; Yixin Chen; Changgang Li; Lizhi Cao; Xiaowen Chen; Senmin Chen; Guosheng Liu; Feiqiu Wen
Journal:  J Cancer Res Clin Oncol       Date:  2016-02       Impact factor: 4.553

5.  Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis.

Authors:  Wanhua Zhang; Pu Kuang; Ting Liu
Journal:  Ann Med       Date:  2019-02-14       Impact factor: 4.709

6.  Silencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemia.

Authors:  Robert J Weeks; Ursula R Kees; Sarah Song; Ian M Morison
Journal:  Mol Cancer       Date:  2010-06-24       Impact factor: 27.401

Review 7.  Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.

Authors:  Qingqing Cai; Kailin Chen; Ken H Young
Journal:  Exp Mol Med       Date:  2015-01-23       Impact factor: 8.718

Review 8.  The Yin and Yang-Like Clinical Implications of the CDKN2A/ARF/CDKN2B Gene Cluster in Acute Lymphoblastic Leukemia.

Authors:  Celia González-Gil; Jordi Ribera; Josep Maria Ribera; Eulàlia Genescà
Journal:  Genes (Basel)       Date:  2021-01-09       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.